Anti-Infective Drugs Market By Type of Product (antibiotics, antivirals, antifungals and others (including anthelminthic and antiprotozoal drugs)), Opportunities and Strategies – Global Forecast To 2022 

Starting Price : $ 4000.00 | Pages : 280 | Published : August 2019 | SKU CODE : o&s097 | Format :

Request Sample

Anti-infective Drugs Market Definition

The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections.

Anti-infective Drugs Market Size

The global market for anti-infective drugs reached a value of nearly $88.5 billion in 2018, having grown at a compound annual growth rate (CAGR) of 7.0% since 2014.

Growth in the historic period resulted from rise in the incidence rates of infectious diseases, aging population and growth of emerging markets. Factors that negatively affected growth in the historic period were low returns of investment, pricing pressures from regulators and patent expiration of drugs.

Going forward, developments in drug discovery procedures, increase in sepsis prevalence and economic growth will drive growth. Factors that could hinder the growth of this market in the future include increasing antimicrobial resistance and reduction in free trade.

Anti-infective Drugs Market Drivers

The key drivers of anti-infective drugs market include:

Developments In Drug Discovery Procedures

The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period.

Anti-infective Drugs Market Restraints

The key restraints on the anti-infective drugs market include:

Supply Shortages Of Anti-Infective Drugs

The global anti-infective drugs market is facing supply shortages of anti-biotic drugs, especially antibiotics, due to the presence of few antibiotics manufacturers in the market. This can be attributed to low profits margins in the industry and exit strategies adopted by the market players. This has given rise to heavy reliance on a few manufacturers, leading to shortages of antibiotics supply, thus restraining the market’s growth. In 2015, a commonly prescribed antibiotic, benzathine penicillin G (BPG), was unavailable in 39 out of 114 countries covered in the World Health Organization’s (WHO) study. Similarly, an explosion at a Chinese manufacturing facility in 2016, the only facility globally producing the active pharmaceutical ingredient (API) needed for manufacturing the piperacillin-tazobactam, caused a global shortage of this antibiotic drug.  Additionally, major antibiotics companies such as Novartis, AstraZeneca, Sanofi, and Allergan are shutting down their antibiotic research operations due to the lack of profitability, which further sets a negative impact of the drugs shortage in the long run in the anti-infective drugs market.

Anti-infective Drugs Market Trends

Major trends influencing the anti-infective drugs market include:

Strategic Collaborations And Agreements

Companies in the anti-infective drugs market are strategically partnering and collaborating with other companies to broaden their product portfolios. In December 2014, Chimerix, Inc. and ContraVir Pharmaceuticals, Inc. entered into a strategic collaboration for the clinical development and commercialization of antiviral drug CMX157. In December 2016, Evotec AG, a biotechnology company, entered into a strategic alliance with Forge Therapeutics, Inc., to advance its novel Gram-negative antibiotic program targeting LpxC for the treatment of bacterial infections. In October 2018, AiCuris, a leading pharmaceutical company in the discovery and development of innovative drugs targeting infectious diseases, and Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery of novel therapeutics, entered into a collaboration to develop novel anti-infective drugs.

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of anti-infective drugs. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. Programs such as the Innovative Medicines Initiative’s (IMI’s) New Drugs for Bad Bugs (ND4BB) program, Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), and Biomedical Advanced Research and Development Authority’s (BARDA) Broad Spectrum Antimicrobials Program have been implemented for the development of novel antibiotics by focusing on R&D gaps. Similarly, Global Antibiotic Research and Development Partnership (GARDP) was set up by the World Health Organization (WHO) and the Drugs for Neglected Diseases Initiative (DNDi) in May 2016. This R&D initiative focuses on the development of new or improved antibiotic treatments.

Opportunities And Recommendations In The Anti-infective Drugs Market

Opportunities – The top opportunities in the global anti-infective drugs market will arise in the antivirals segment which will gain $14.11 billion of global annual sales by 2022. The anti-infective drugs market size will gain the most in the USA at $10.55 billion. Market-trend-based strategies for the anti-infective drugs market include entering into collaborative partnerships to broaden product portfolios, focusing on research and development on drug resistance, adopting 3D printing technology to reduce pre-clinical costs. Player-adopted strategies in the anti-infective drugs market include broadening the product portfolios through strategic collaborations and acquisitions, and focusing on new drug development through investments in research and development.

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the anti-infective drugs manufacturing companies to expand in emerging markets, invest in research and development to combat drug resistance and development of new anti-infective drugs, adopt skimmed and competitive pricing strategies, and integrate big data analytics to manage clinical trial data, among other strategies.

Anti-infective Drugs Market Segmentation

The anti- infective drugs market is segmented by type of product.
By Product Type- The anti-infective drugs market can be segmented by product type into
    • a) Antibiotics
    • b) Antivirals
    • c) Antifungals
    • d) Others (Anthelminthic, Antiprotozoal)
Antivirals had the highest growth rate of nearly 7.4% during the historic period. The fastest market growth can be attributed to rapid increase in the access to antiviral treatment of sexually transmitted diseases such as Hepatitis B and HIV/AIDS.
Sub-Segmentation The antibiotics market can be sub-segmented by product type into
    • a) ß-Lactams
    • b) Quinolones
    • c) Macrolides
    • d) Aminoglycosides
    • e) Others
The antivirals market can be sub-segmented by therapeutic type into
    • a) HIV AIDS Therapeutics
    • b) Hepatitis Therapeutics
    • c) Herpes Therapeutics
    • d) Influenza Therapeutics
The antifungals market can be sub-segmented by product type into
    • a) Azoles
    • b) Others
By Geography- The anti-infective drugs market is segmented into
    • o North America
      • USA
      • Canada
      • Mexico
    • o Western Europe
      • Austria
      • Belgium
      • Denmark
      • Finland
      • UK
      • France
      • Germany
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Portugal
      • Spain
      • Italy
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • Hong Kong
      • Indonesia
      • Malaysia
      • New Zealand
      • Philippines
      • Singapore
      • South Korea
      • Thailand
      • Vietnam
    • o Eastern Europe
      • Czech Republic
      • Poland
      • Romania
      • Russia
    • o South America
      • Argentina
      • Brazil
      • Chile
      • Colombia
      • Peru
      • Venezuela
    • o Middle East
      • Saudi Arabia
      • Israel
      • Turkey
      • UAE
    • o Africa
      • Egypt
      • Nigeria
      • South Africa
North America was the largest market for anti-infective drugs, accounting for a 47.7% of the global market in 2018. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market.

Anti-infective Drugs Market Competitive Landscape

Major Competitors are:
    • · Gilead Sciences
    • · GlaxoSmithKline plc
    • · Merck & Co.
    • · Teva Pharmaceutical Industries Ltd.
    • · Johnson & Johnson
Other Competitors Include:
    • • Boehringer Ingelheim GmbH
    • • Pfizer
    • • Mylan N.V.
    • • Bristol-Myers Squibb
    • • F. Hoffmann-La Roche Ltd
    • • Shanghai Pharmaceuticals
    • • Shanghai Fosun Pharmaceutical
    • • Cipla
    • • Dr. Reddy’s Laboratories Ltd.
    • • Sun Pharma
    • • Takeda Pharmaceutical Company Ltd.
    • • Otsuka Pharmaceutical Co. Ltd.
    • • Daiichi Sankyo
    • • Roche
    • • Novartis
    • • Sanofi
    • • AstraZeneca
    • • Novo Nordisk
    • • Bayer
    • • Sotex
    • • Microgen
    • • Pharmstandard
    • • STADA CIS Russian Holding
    • • Amgen
    • • AbbVie
    • • Eli Lilly and Company
    • • Q Pharm
    • • 3M Pharmaceuticals
    • • União Quimica
    • • Ache
    • • EMS Pharma
    • • Hypermarcas
    • • Medley
    • • Teuto Brasileiro
    • • Biolab Farmaceutica
    • • Cristalia
    • • Libbs
    • • Saudi Pharmaceutical Industries
    • • Gulf Pharmaceutical Industries (Julphar)
    • • Adcock Ingram
    • • Aspen

  1. 1. Anti-Infective Drugs Market Executive Summary
  2. 2. Table Of Contents
  3. 3. List Of Figures
  4. 4. List Of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6.1. Segmentation By Geography
    • 6.2. Segmentation By Product Type
  7. 7. Anti-Infective Drugs Market Characteristics
    • 7.1. Market Definition
    • 7.2. Market Segmentation By Product Type
      • 7.2.1. Antibiotics
      • 7.2.2. Antivirals
      • 7.2.3. Antifungals
      • 7.2.4. Others (Anthelminthic, Antiprotozoal)
  8. 8. Anti-Infective Drugs Market Product Analysis
  9. 9. Anti-Infective Drugs Market Supply Chain Analysis
    • 9.1. Raw Material Suppliers
    • 9.2. Contract Research Organization (CRO)
    • 9.3. Anti-Infective Drugs Manufacturer
    • 9.4. Contract Manufacturing Organization (CMO)
    • 9.5. Wholesalers/Distributors
    • 9.6. Retailers (Pharmacies) And Hospitals
    • 9.7. End-Users
  10. 10. Anti-Infective Drugs Market Customer Information
    • 10.1. Willingness Towards Alternative Distribution And Dispensing Of Antiviral Drugs
    • 10.2. Extensive Use Of Antibiotics In Low Income Countries
    • 10.3. Anti-Parasitic Drugs May Improve Long Term Clinical Outcomes
    • 10.4. Antifungal Drugs Are Widely Used By The Pediatric Population
    • 10.5. Frequency Of Anti-Malarial Drug Use
    • 10.6. High Proportion of Americans Consume Prescription Drugs
    • 10.7. Consumers Find Generics As Good As Prescription Drugs
  11. 11. Anti-Infective Drugs Market Trends And Opportunities
    • 11.1. Strategic Collaborations And Agreements
    • 11.2. Demand For New Medicines For Drug-Resistant Infections
    • 11.3. Global Research Initiatives And Funding
    • 11.4. 3D Printing Technology
    • 11.5. Termination Of R&D Pipelines Of Anti-Infective Drugs
    • 11.6. Diversification Of Portfolios And Enhanced Focus On The Chronic Segment
    • 11.7. Increasing Number Of Pipeline Studies And Drug Development
  12. 12. Anti-Infective Drugs Market Opportunity Assessment, PESTEL Analysis
    • 12.1. Political
      • 12.1.1. Government Initiatives
      • 12.1.2. Political Uncertainties
    • 12.2. Economic
      • 12.2.1. Emerging Economies
      • 12.2.2. Inflated Drug Prices
      • 12.2.3. Rising Disposable Incomes
    • 12.3. Social
      • 12.3.1. Aging Global Population
      • 12.3.2. Health Consciousness And Awareness
      • 12.3.3. Shortages Of Human Resources
    • 12.4. Technological
      • 12.4.1. Internet Connectivity Rising Awareness
    • 12.5. Environmental
    • 12.6. Environmental Pollution
    • 12.7. Natural Disasters
    • 12.8. Legal
      • 12.8.1. Stringent Regulations
      • 12.8.2. Lengthy Drug Approval Processes
  13. 13. Global Anti-Infective Drugs Market Size And Growth
    • 13.1. Market Size
    • 13.2. Historic Market Growth, Value ($ Billion)
      • 13.2.1. Drivers Of The Market 2014-18
        • 13.2.1.1. Rise In Incidence Rates Of Infectious Diseases
        • 13.2.1.2. Population Aging
        • 13.2.1.3. Growth Of Emerging Markets
      • 13.2.2. Restraints On The Market 2014-18
        • 13.2.2.1. Patent Expiration Of Drugs
        • 13.2.2.2. Low Returns On Investments
    • 13.3. Forecast Market Growth, Value ($ Billion)
      • 13.3.1. Drivers Of The Market 2018-22
        • 13.3.1.1. Developments In Drug Discovery Procedures
        • 13.3.1.2. Increase In The Sepsis Prevalence
        • 13.3.1.3. Economic Growth
      • 13.3.2. Restraints On The Market 2018-22
        • 13.3.2.1. Increasing Antimicrobial Resistance
        • 13.3.2.2. Supply Shortages Of Anti-Infective Drugs
        • 13.3.2.3. Reductions In Free Trade
  14. 14. Anti-Infective Drugs Market Regional Analysis
    • 14.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)
    • 14.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region
    • 14.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  15. 15. Global Anti-Infective Drugs Market Segmentation
    • 15.1. Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
    • 15.2. Global Antibiotics Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
    • 15.3. Global Antivirals Market, Segmentation By Therapeutic Type, 2014 - 2022, Value ($ Billion)
    • 15.4. Global Antifungals Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
  16. 16. Global Anti-Infective Drugs Market Metrics
    • 16.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
    • 16.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
  17. 17. Asia-Pacific Anti-Infective Drugs Market
    • 17.1. Asia-Pacific Anti-infective Drugs Market Overview
      • 17.1.1. Region Information
      • 17.1.2. Market Information
      • 17.1.3. Background Information
      • 17.1.4. Government Initiatives
      • 17.1.5. Regulations
      • 17.1.6. Regulatory Bodies
      • 17.1.7. Tax Levied
      • 17.1.8. Associations
      • 17.1.9. Corporate Tax Structure
      • 17.1.10. Investments
      • 17.1.11. Major Companies
    • 17.2. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 17.3. Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 17.4. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 17.5. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
    • 17.6. Asia-Pacific Anti-Infective Drugs Market Metrics
    • 17.7. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Asia-Pacific Countries
    • 17.8. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
      • 17.8.1. Australia Anti-Infective Drugs Market
      • 17.8.2. Australia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 17.8.3. China Anti-Infective Drugs Market
        • 17.8.3.1. China Anti-Infective Drugs Market Overview
          • 17.8.3.1.1. Country Information
          • 17.8.3.1.2. Market Information
          • 17.8.3.1.3. Background Information
          • 17.8.3.1.4. Government Initiatives
          • 17.8.3.1.5. Regulations
          • 17.8.3.1.6. Regulatory Bodies
          • 17.8.3.1.7. Tax Levied
          • 17.8.3.1.8. Associations
          • 17.8.3.1.9. Corporate Tax Structure
          • 17.8.3.1.10. Investments
          • 17.8.3.1.11. Major Companies
        • 17.8.3.2. China Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 17.8.4. Hong Kong Anti-Infective Drugs Market
        • 17.8.4.1. Hong Kong Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.5. India Anti-Infective Drugs Market
      • 17.8.6. India Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 17.8.7. Indonesia Anti-Infective Drugs Market
        • 17.8.7.1. Indonesia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.8. Japan Anti-Infective Drugs Market
        • 17.8.8.1. Japan Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 17.8.9. Malaysia Anti-Infective Drugs Market
      • 17.8.10. Malaysia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.11. New Zealand Anti-Infective Drugs Market
      • 17.8.12. New Zealand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.13. Philippines Anti-Infective Drugs Market
        • 17.8.13.1. Philippines Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.14. Singapore Anti-Infective Drugs Market
        • 17.8.14.1. Singapore Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.15. South Korea Anti-Infective Drugs Market
      • 17.8.16. South Korea Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.17. Thailand Anti-Infective Drugs Market
      • 17.8.18. Thailand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 17.8.19. Vietnam Anti-Infective Drugs Market
        • 17.8.19.1. Vietnam Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
  18. 18. Western Europe Anti-Infective Drugs Market
    • 18.1. Western Europe Anti-infective Drugs Market Overview
      • 18.1.1. Region Information
      • 18.1.2. Market Information
      • 18.1.3. Background Information
      • 18.1.4. Government Initiatives
      • 18.1.5. Regulations
      • 18.1.6. Regulatory Bodies
      • 18.1.7. Tax Levied
      • 18.1.8. Associations
      • 18.1.9. Corporate Tax Structure
      • 18.1.10. Investments
      • 18.1.11. Major Companies
    • 18.2. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 18.3. Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 18.4. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 18.5. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
    • 18.6. Western Europe Anti-Infective Drugs Market Metrics
      • 18.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Western Europe Countries
    • 18.7. Western Europe Anti-Infective Drugs Market: Country Analysis
      • 18.7.1. Austria Anti-Infective Drugs Market
        • 18.7.1.1. Austria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.2. Belgium Anti-Infective Drugs Market
        • 18.7.2.1. Belgium Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.3. Denmark Anti-Infective Drugs Market
        • 18.7.3.1. Denmark Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.4. Finland Anti-Infective Drugs Market
        • 18.7.4.1. Finland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.5. France Anti-Infective Drugs Market
        • 18.7.5.1. France Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 18.7.6. Germany Anti-Infective Drugs Market
        • 18.7.6.1. Germany Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 18.7.7. Ireland Anti-Infective Drugs Market
        • 18.7.7.1. Ireland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.8. Italy Anti-Infective Drugs Market
        • 18.7.8.1. Italy Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 18.7.9. Netherlands Anti-Infective Drugs Market
        • 18.7.9.1. Netherlands Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.10. Norway Anti-Infective Drugs Market
        • 18.7.10.1. Norway Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.11. Portugal Anti-Infective Drugs Market
      • 18.7.12. Portugal Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.13. Spain Anti-Infective Drugs Market
        • 18.7.13.1. Spain Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 18.7.14. Sweden Anti-Infective Drugs Market
        • 18.7.14.1. Sweden Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.15. Switzerland Anti-Infective Drugs Market
        • 18.7.15.1. Switzerland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 18.7.16. UK Anti-Infective Drugs Market
        • 18.7.16.1. UK Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  19. 19. Eastern Europe Anti-Infective Drugs Market
    • 19.1. Eastern Europe Anti-infective Drugs Market Overview
      • 19.1.1. Region Information
      • 19.1.2. Market Information
      • 19.1.3. Background Information
      • 19.1.4. Government Initiatives
      • 19.1.5. Regulations
      • 19.1.6. Regulatory Bodies
      • 19.1.7. Tax Levied
      • 19.1.8. Associations
      • 19.1.9. Corporate Tax Structure
      • 19.1.10. Investments
      • 19.1.11. Major Companies
    • 19.2. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 19.3. Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 19.4. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 19.5. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
    • 19.6. Eastern Europe Anti-Infective Drugs Market Metrics
      • 19.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Eastern Europe Countries
    • 19.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
      • 19.7.1. Czech Republic Anti-Infective Drugs Market
        • 19.7.1.1. Czech Republic Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 19.7.2. Poland Anti-Infective Drugs Market
        • 19.7.2.1. Poland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 19.7.3. Romania Anti-Infective Drugs Market
        • 19.7.3.1. Romania Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 19.7.4. Russia Anti-Infective Drugs Market
        • 19.7.4.1. Russia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
  20. 20. North America Anti-Infective Drugs Market
    • 20.1. North America Anti-infective Drugs Market Overview
      • 20.1.1. Region Information
      • 20.1.2. Market Information
      • 20.1.3. Background Information
      • 20.1.4. Government Initiatives
      • 20.1.5. Regulatory Bodies
      • 20.1.6. Tax Levied
      • 20.1.7. Associations
      • 20.1.8. Corporate Tax Structure
      • 20.1.9. Investments
      • 20.1.10. Major Companies
    • 20.2. North America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 20.3. North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 20.4. North America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 20.5. Growth has slowed in most countries of the North America anti-infective drugs market, accelerating in Mexico.
    • 20.6. North America Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
    • 20.7. North America Anti-Infective Drugs Market Metrics
      • 20.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, North America Countries
    • 20.8. North America Anti-Infective Drugs Market: Country Analysis
      • 20.8.1. USA Anti-Infective Drugs Market
        • 20.8.1.1. USA Anti-infective Drugs Market Overview
          • 20.8.1.1.1. Country Information
          • 20.8.1.1.2. Market Information
          • 20.8.1.1.3. Background Information
          • 20.8.1.1.4. Government Initiatives
          • 20.8.1.1.5. Regulatory Bodies
          • 20.8.1.1.6. Tax Levied
          • 20.8.1.1.7. Associations
          • 20.8.1.1.8. Corporate Tax Structure
          • 20.8.1.1.9. Investments
          • 20.8.1.1.10. Major Companies
        • 20.8.1.2. USA Anti-Infective Drugs Market
        • 20.8.1.3. USA Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 20.8.2. Canada Anti-Infective Drugs Market
        • 20.8.2.1. Canada Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 20.8.3. Mexico Anti-Infective Drugs Market
      • 20.8.4. Mexico Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
  21. 21. South America Anti-Infective Drugs Market
    • 21.1. South America Anti-infective Drugs Market Overview
      • 21.1.1. Region Information
      • 21.1.2. Market Information
      • 21.1.3. Background Information
      • 21.1.4. Government Initiatives
      • 21.1.5. Regulations
      • 21.1.6. Regulatory Bodies
      • 21.1.7. Tax Levied
      • 21.1.8. Associations
      • 21.1.9. Corporate Tax Structure
      • 21.1.10. Investments
      • 21.1.11. Major Companies
    • 21.2. South America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 21.3. South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 21.4. South America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 21.5. Growth has slowed in most counties of the South American anti-infective drugs market, accelerating in Colombia and Venezuela.
    • 21.6. South America Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
    • 21.7. South America Anti-Infective Drugs Market Metrics
      • 21.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, South America Countries
    • 21.8. South America Anti-Infective Drugs Market: Country Analysis
      • 21.8.1. Argentina Anti-Infective Drugs Market
        • 21.8.1.1. Argentina Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 21.8.2. Brazil Anti-Infective Drugs Market
        • 21.8.2.1. Brazil Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
      • 21.8.3. Chile Anti-Infective Drugs Market
        • 21.8.3.1. Chile Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 21.8.4. Colombia Anti-Infective Drugs Market
        • 21.8.4.1. Colombia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 21.8.5. Peru Anti-Infective Drugs Market
        • 21.8.5.1. Peru Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 21.8.6. Venezuela Anti-Infective Drugs Market
        • 21.8.6.1. Venezuela Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
  22. 22. Middle East Anti-Infective Drugs Market
    • 22.1. Middle East Anti-infective Drugs Market Overview
      • 22.1.1. Region Information
      • 22.1.2. Market Information
      • 22.1.3. Background Information
      • 22.1.4. Government Initiatives
      • 22.1.5. Regulatory Bodies
      • 22.1.6. Tax Levied
      • 22.1.7. Corporate Tax Structure
      • 22.1.8. Investments
      • 22.1.9. Major Companies
    • 22.2. Middle East Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 22.3. Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 22.4. Middle East Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 22.5. Middle East Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
    • 22.6. Middle East Anti-Infective Drugs Market Metrics
      • 22.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Middle East Countries
    • 22.7. Middle East Anti-Infective Drugs Market: Country Analysis
      • 22.7.1. Israel Anti-Infective Drugs Market
        • 22.7.1.1. Israel Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 22.7.2. Saudi Arabia Anti-Infective Drugs Market
        • 22.7.2.1. Saudi Arabia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 22.7.3. Turkey Anti-Infective Drugs Market
        • 22.7.3.1. Turkey Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 22.7.4. UAE Anti-Infective Drugs Market
      • 22.7.5. UAE Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
  23. 23. Africa Anti-Infective Drugs Market
    • 23.1. Africa Anti-infective Drugs Market Overview
      • 23.1.1. Region Information
      • 23.1.2. Market Information
      • 23.1.3. Background Information
      • 23.1.4. Government Initiatives
      • 23.1.5. Regulations
      • 23.1.6. Regulatory Bodies
      • 23.1.7. Tax Levied
      • 23.1.8. Corporate Tax Structure
      • 23.1.9. Investments
      • 23.1.10. Major Companies
    • 23.2. Africa Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 23.3. Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
    • 23.4. Africa Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
    • 23.5. Africa Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
    • 23.6. Africa Anti-Infective Drugs Market Metrics
      • 23.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Africa Countries
    • 23.7. Africa Anti-Infective Drugs Market: Country Analysis
      • 23.7.1. Egypt Anti-Infective Drugs Market
        • 23.7.1.1. Egypt Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 23.7.2. Nigeria Anti-Infective Drugs Market
        • 23.7.2.1. Nigeria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
      • 23.7.3. South Africa Anti-Infective Drugs Market
      • 23.7.4. South Africa Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
  24. 24. Global Anti-infective Drugs Market Competitive Landscape
    • 24.1. Company Profiles
      • 24.1.1. Gilead Sciences
        • 24.1.1.1. Company Overview
        • 24.1.1.2. Products And Services
        • 24.1.1.3. Product Pipeline
        • 24.1.1.4. Business Strategy
        • 24.1.1.5. Financial Overview
      • 24.1.2. GlaxoSmithKline
        • 24.1.2.1. Company Overview
        • 24.1.2.2. Products And Services
        • 24.1.2.3. Product Pipeline
        • 24.1.2.4. Business Strategy
        • 24.1.2.5. Financial Overview
      • 24.1.3. Merck & Co
        • 24.1.3.1. Company Overview
        • 24.1.3.2. Products And Services
        • 24.1.3.3. Product Pipeline
        • 24.1.3.4. Business Strategy
        • 24.1.3.5. Financial Overview
      • 24.1.4. Teva Pharmaceutical Industries Ltd.
        • 24.1.4.1. Company Overview
        • 24.1.4.2. Products And Services
        • 24.1.4.3. Business Strategy
        • 24.1.4.4. Financial Overview
      • 24.1.5. Johnson & Johnson
        • 24.1.5.1. Company Overview
        • 24.1.5.2. Products And Services
        • 24.1.5.3. Product Pipeline
        • 24.1.5.4. Business Strategy
        • 24.1.5.5. Financial Overview
  25. 25. Anti-Infective Drugs Market, Key Mergers And Acquisitions
    • 25.1. Cumberaland Pharmaceuticals Acquired Anti- Infective Injection Business Of Theravance Biopharma
    • 25.2. Boston Pharmaceuticals Acquired Novartis’ Three Novel Anti-Infective Drugs
    • 25.3. Boston Pharmaceuticals Acquired Five Development Programs From GlaxoSmithKline
    • 25.4. Redx Pharma Signned An Option Deal For Anti-Infective Program With Deinove
    • 25.5. Melinta Therapeutics Acquired The Medicines Company’s Infectious Disease Portfolio
    • 25.6. Melinta Therapeutics Merged With Cempra
    • 25.7. Pfizer Acquired Small Molecule Anti-Infective Business From AstraZeneca
    • 25.8. Citius Pharmaceuticals Acquired Leonard-Meron Biosciences
    • 25.9. Johnson & Johnson Acquired Novira Therapeutics, Inc.
    • 25.10. Johnson & Johnson Acquired Alios
  26. 26. Market Background: Pharmaceutical Drugs Market
    • 26.1. Pharmaceutical Drugs Market Characteristics
    • 26.2. Market Segmentation By Product Type
      • 26.2.1. Musculoskeletal Drugs
      • 26.2.2. Cardiovascular Drugs
      • 26.2.3. Oncology Drugs
      • 26.2.4. Anti-Infective Drugs
      • 26.2.5. Metabolic Disorders Drugs
      • 26.2.6. Central Nervous System Drugs
      • 26.2.7. Genito-Urinary Drugs
      • 26.2.8. Respiratory Diseases Drugs
      • 26.2.9. Gastrointestinal Drugs
      • 26.2.10. Hematology Drugs
      • 26.2.11. Dermatology Drugs
      • 26.2.12. Ophthalmology Drugs
      • 26.2.13. Pharmaceutical Drugs Market Segmentation
    • 26.3. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
    • 26.4. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
    • 26.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  27. 27. Global Anti-Infective Drugs Market Opportunities And Strategies
    • 27.1. Global Anti-Infective Drugs Market In 2022 – Countries Offering Most New Opportunities
    • 27.2. Global Anti-Infective Drugs Market In 2022 – Segments Offering Most New Opportunities
    • 27.3. Global Antibiotics Market In 2022 – Sub-Segments Offering Most New Opportunities
      • 27.3.1. Global Antifungals Market In 2022 – Sub-Segments Offering Most New Opportunities
      • 27.3.2. Global Antivirals Market In 2022 – Sub-Segments Offering Most New Opportunities
    • 27.4. Global Anti-Infective Drugs Market In 2022 – Growth Strategies
      • 27.4.1. Market Trend Based Strategies
      • 27.4.2. Competitor Strategies
  28. 28. Anti-Infective Drugs Market, Conclusions And Recommendations
    • 28.1. Conclusions
    • 28.2. Recommendations
      • 28.2.1. Product
      • 28.2.2. Price
      • 28.2.3. Place
      • 28.2.4. Promotion
      • 28.2.5. People
  29. 29. Appendix
    • 29.1. Market Data Sources
    • 29.2. Research Methodology
    • 29.3. Currencies
    • 29.4. Research Inquiries
    • 29.5. The Business Research Company
    • 29.6. Copyright and Disclaimer

List Of Tables

    Table 1: Anti-Infective Drugs Market Product Analysis – Product Examples
  • Table 2: Global Anti-Infective Drugs Market, Historic Market Size, 2014– 2018, $ Billion
  • Table 3: Global Anti-Infective Drugs Market, Forecast Market Size, 2018– 2022, $ Billion
  • Table 4: Global Anti-Infective Drugs Market, 2018, Split By Region
  • Table 5: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
  • Table 6: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  • Table 7: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 8: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 9: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
  • Table 10: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 11: Global Anti-Infective Drugs Market Value, Market Size As A Percentage Of Global GDP, 2014 – 2022
  • Table 12: Global Anti-Infective Drugs Market, Per Capita Average Anti-Infective Drugs Expenditure, 2014-2022, ($)
  • Table 13: Asia-Pacific, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2016
  • Table 14:Asia-Pacific, Number Of Buruli Ulcer Cases, 2013-2017
  • Table 15: Asia-Pacific, Trends In Indigenous Malaria Cases, 2013-2017
  • Table 16: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 17: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 18: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 19: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 20: Asia-Pacific Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 21: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 22: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 23: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 24: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 25: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 26: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 27: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 28: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 29: Philippines Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 30: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 31: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 32: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 33: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 34: Western Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
  • Table 35: Corporate Tax Structure In Western Europe Countries, %
  • Table 36: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 37: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 38: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 39: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 40: Western Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 41: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 42: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 43: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 44: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 45: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 46: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 47: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 48: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 49: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 50: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 51: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 52: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 53: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 54: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 55: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 56: Eastern Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
  • Table 57: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 58: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 59: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 60: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 61: Eastern Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 62: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 63: Poland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 64: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 65: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 66: South America, Defined Daily Doses (DDD) Per 1,000 Inhabitants Per Day, 2013 – 2017
  • Table 67: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 68: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 69: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 70: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 71: North America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 72: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 73: Canada  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 74: Mexico  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 75: South America, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
  • Table 76: South America, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 – 2017
  • Table 77: South America, Reported Number Of Individuals Treated For Onchocerciasis, 2013 – 2017
  • Table 78: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 79: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 80: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 81: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 82: South America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 83: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 84: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 85: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 86: Colombia  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 87: Peru  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 88: Venezuela  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 89: Middle East, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
  • Table 90: Middle East, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 – 2017
  • Table 91: Middle East, Reported Number Of Individuals Treated For Onchocerciasis, 2013 – 2017
  • Table 92: Middle East, Trends In Indigenous Malaria Cases, 2013 – 2017
  • Table 93: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 94: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 95: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 96: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 97: Middle East Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 98: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 99: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 100: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 101: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 102: Africa, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
  • Table 103: Africa, Number Of Buruli Ulcer Cases, 2013 – 2017
  • Table 104: Africa, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 – 2017
  • Table 105: Africa, Reported Number Of Individuals Treated For Onchocerciasis, 2013 – 2017
  • Table 106: Africa, Trends In Indigenous Malaria Cases, 2013 – 2017
  • Table 107: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 108: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 109: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Table 110: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Table 111: Africa Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
  • Table 112: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 113: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 114: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Table 115: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
  • Table 116: Other Major Competitors In The Global Anti-infective Drugs Market
  • Table 117: Gilead Sciences– Anti-infective Drugs In Pipeline
  • Table 118: Gilead Sciences – Financial Performance, $ Billion
  • Table 119: Gilead Sciences – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Table 120: GlaxoSmithKline plc – Anti-infective Drugs In Pipeline
  • Table 121: GlaxoSmithKline – Financial Performance, $ Billion
  • Table 122: GlaxoSmithKline – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Table 123: Merck & Co – Anti-infective Drugs In Pipeline
  • Table 124: Merck & Co. – Financial Performance, $ Billion
  • Table 125: Merck & Co. – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Table 126: Teva Pharmaceutical Industries Ltd. – Financial Performance, $ Billion
  • Table 127: Teva Pharmaceutical Industries Ltd. – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Table 128: Johnson & Johnson – Anti-infective Drugs In Pipeline
  • Table 129: Johnson & Johnson – Financial Performance, $ Billion
  • Table 130: Johnson & Johnson – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Table 131: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Table 132: Global Pharmaceutical Drugs Market, 2018, Split By Region
  • Table 133: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
  • Table 134: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 – 2022, By Country
  • Table 135: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 – 2022, By Segment
  • Table 136: Global Antibiotics Market Size Gain ($ Billion), 2018 – 2022, By Segment
  • Table 137: Global Antifungals Market Size Gain ($ Billion), 2018 – 2022, By Segment
  • Table 138: Global Antivirals Market Size Gain ($ Billion), 2018 – 2022, By Segment
  • Table 139: Anti-Infective Drugs Market Data Sources

List Of Figures

    Figure 1: Global Anti-infective Drugs Market Segmentation, By Product Type
  • Figure 2: Global Anti-Infective Drugs Industry, Supply Chain Analysis
  • Figure 3: Global Anti-Infective Drugs Market, PESTEL Analysis
  • Figure 4:  Global Anti-Infective Drugs Market, Historic Market Size, 2014-2018, $ Billion
  • Figure 5:  Global Anti-Infective Drugs Market, Forecast Market Size, 2018-2022, $ Billion
  • Figure 6: Global Anti-Infective Drugs Market, 2018, Split By Region
  • Figure 7: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
  • Figure 8: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 9: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 10: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 11: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
  • Figure 12: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 13: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 14: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 15: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 16: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 17: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 18: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 19: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 20: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 21: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 22: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 23: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 24: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 25: Philipines Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 26: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 27: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 28: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 29: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 30: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 31: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 32: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 33: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 34: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 35: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 36: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 37: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 38: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 39: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 40: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 41: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 42: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 43: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 44: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 45: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 46: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 47: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 48: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 49: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 50: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 51: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 52: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 53: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 54: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 55: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 56: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 57: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 58: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 59: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 60: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 61: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 62: Canada  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 63: Mexico  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 64: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 65: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 66: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 67: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 68: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 69: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 70: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 71: Colombia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 72: Peru Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 73: Venezuela  Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 74: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 75: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 76: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 77: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 78: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 79: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 80: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 81: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 82: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 83: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 84: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
  • Figure 85: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
  • Figure 86: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 87: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 88: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
  • Figure 89: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
  • Figure 90: Gilead Sciences – Financial Performance, $ Billion
  • Figure 91: Gilead Sciences – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Figure 92: GlaxoSmithKline – Financial Performance, $ Billion
  • Figure 93: GlaxoSmithKline – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Figure 94: Merck & Co. – Financial Performance, $ Billion
  • Figure 95: Merck & Co. – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Figure 96: Teva Pharmaceutical Industries Ltd. – Financial Performance, $ Billion
  • Figure 97: Teva Pharmaceutical Industries Ltd. – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Figure 98: Johnson & Johnson – Financial Performance, $ Billion
  • Figure 99: Johnson & Johnson – Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
  • Figure 100: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
  • Figure 101: Global Pharmaceutical Drugs Market, 2018, Split By Region
  • Figure 102: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)